Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis

Emile Ferrari1, Mustapha Benhamou, Pierre Cerboni

  • 1Cardiology Department, Pasteur Hospital, 30 Avenue de la voie Romaine, Nice, Alpes Maritimes 06200, France. ferrari.e@chu-nice.fr

Insights

Stopping aspirin therapy in patients with coronary disease increases the risk of recurrent heart events, including late stent thrombosis. This withdrawal is a significant factor in coronary recurrences.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Aspirin is crucial for managing coronary artery disease.
  • Concerns about bleeding and compliance often lead to aspirin discontinuation.
  • The impact of aspirin withdrawal on coronary patients is not well understood.

Purpose of the Study:

  • To investigate the occurrence and impact of aspirin withdrawal in patients experiencing coronary events.
  • To determine if aspirin cessation is linked to relapses in coronary artery disease patients.

Main Methods:

  • A cohort of 1,236 patients hospitalized for acute coronary syndrome (ACS) between 1999 and 2002 were surveyed.
  • The study assessed the interruption of aspirin intake among these patients.
  • Data on subsequent coronary events and stent thrombosis were collected.

Main Results:

  • Aspirin withdrawal preceded 13.3% of recurrent coronary events, with 4.1% of all events occurring within one month of cessation.
  • Patients who stopped aspirin had a higher incidence of ST-segment elevation ACS (39% vs. 18%).
  • Late stent thrombosis occurred in 20% of cases, with a mean delay of 10 days between withdrawal and event.

Conclusions:

  • Aspirin withdrawal poses a significant risk for new coronary events in patients with coronary disease.
  • Late stent thrombosis is a notable complication following aspirin cessation.
  • Further prospective studies are needed to precisely quantify coronary recurrences after aspirin withdrawal.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...